Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
1.380
+0.010 (0.73%)
Mar 6, 2026, 4:00 PM EST - Market closed
Jasper Therapeutics Market Cap
Jasper Therapeutics has a market cap or net worth of $38.62 million as of March 6, 2026. Its market cap has decreased by -58.21% in one year.
Market Cap
38.62M
Enterprise Value
-10.58M
1-Year Change
-58.21%
Ranking
Category
Stock Price
$1.38
Market Cap Chart
Since January 10, 2020, Jasper Therapeutics's market cap has decreased from $122.75M to $38.62M, a decrease of -68.54%. That is a compound annual growth rate of -17.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 38.62M | -24.59% |
| Dec 31, 2025 | 51.21M | -84.03% |
| Dec 31, 2024 | 320.73M | 264.33% |
| Dec 29, 2023 | 88.03M | 294.73% |
| Dec 30, 2022 | 22.30M | -94.26% |
| Dec 31, 2021 | 388.71M | 210.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Palatin Technologies | 40.55M |
| Lite Strategy | 40.36M |
| Tevogen Bio Holdings | 40.18M |
| Veru Inc. | 40.13M |
| Aligos Therapeutics | 40.06M |
| NovaBay Pharmaceuticals | 39.97M |
| Xilio Therapeutics | 39.52M |
| Sensei Biotherapeutics | 39.23M |